Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised-controlled Trial of an Oral Microbiome Immunity Formula in Reducing Development of Long-term Co-morbidities in Recovered COVID-19 Patients

NCT04950803 is registered in ClinicalTrials.gov with Chinese University of Hong Kong as lead sponsor.

NCT NCT04950803
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04950803 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised-controlled Trial of an Oral Microbiome Immunity Formula in Reducing Development of Long-term Co-morbidities in Recovered COVID-19 Patients
Lead sponsor
Chinese University of Hong Kong
Phase
Not applicable
Overall status
Active, not recruiting
Start date
June 25, 2021
Completion date
December 31, 2027
Enrollment
448 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, probiotic